Twist Bioscience Corporation (TWST)

NASDAQ: TWST · IEX Real-Time Price · USD
38.20
-0.42 (-1.09%)
At close: Feb 23, 2024, 4:00 PM
38.40
+0.20 (0.52%)
After-hours: Feb 23, 2024, 5:45 PM EST

Twist Bioscience Income Statement

Millions USD. Fiscal year is Oct - Sep.
Year 20232022202120202019201820172016
Revenue
245.11203.57132.3390.154.3925.4310.772.27
Revenue Growth (YoY)
20.41%53.83%46.87%65.67%113.89%136.16%374.53%-
Cost of Revenue
155.38119.3380.6261.4147.4332.1924.029.42
Gross Profit
89.7384.2451.7128.696.96-6.76-13.25-7.15
Selling, General & Admin
189.74212.95135.9103.2780.1343.4526.0618.27
Research & Development
106.89120.3169.0743.0135.6820.3519.1718.23
Other Operating Expenses
10.26-14.25-0.5322.50000
Operating Expenses
306.89319.01204.44168.77115.8163.845.2336.5
Operating Income
-217.16-234.78-152.73-140.08-108.85-70.56-58.48-43.66
Interest Expense / Income
0.010.080.370.791.291.310.910.75
Other Expense / Income
-13.7-6.580.94-1.32-2.77-0.88-0.36-0.31
Pretax Income
-203.47-228.27-154.03-139.55-107.38-70.99-59.03-44.09
Income Tax
1.15-10.41-1.930.380.290.240.280
Net Income
-204.62-217.86-152.1-139.93-107.67-71.24-59.31-44.09
Shares Outstanding (Basic)
5754483927322
Shares Outstanding (Diluted)
5754483927322
Shares Change
5.57%11.68%23.12%42.71%883.24%15.31%29.56%-
EPS (Basic)
-3.60-4.04-3.15-3.57-3.92-25.51-24.49-23.58
EPS (Diluted)
-3.60-4.04-3.15-3.57-3.92-25.51-24.49-23.58
Free Cash Flow
-170.25-226.24-139.31-152.12-102.67-69.84-57.63-44.82
Free Cash Flow Per Share
-2.99-4.20-2.89-3.88-3.74-25.00-23.79-23.97
Gross Margin
36.61%41.38%39.08%31.85%12.80%-26.59%-123.09%-315.20%
Operating Margin
-88.60%-115.33%-115.41%-155.47%-200.15%-277.50%-543.16%-1924.02%
Profit Margin
-83.48%-107.02%-114.94%-155.31%-197.98%-280.16%-550.85%-1943.06%
Free Cash Flow Margin
-69.46%-111.14%-105.27%-168.84%-188.79%-274.65%-535.24%-1975.36%
EBITDA
-171.58-191.55-141.67-133.13-99.97-63.95-53.1-39.11
EBITDA Margin
-70.00%-94.10%-107.05%-147.76%-183.82%-251.52%-493.21%-1723.80%
Depreciation & Amortization
31.8836.6411.995.636.115.735.024.23
EBIT
-203.46-228.19-153.66-138.76-106.08-69.68-58.13-43.34
EBIT Margin
-83.01%-112.10%-116.12%-154.01%-195.06%-274.04%-539.84%-1910.18%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).